The CD5 antigen is a 67 kDa transmembrane glycoprotein expressed on the surface of practically all mature human T-cells (about 10% of CD4+ T-cells being CD5 negative). In immature (CD34+) T-cells, CD5 is weakly expressed, the intensity of expression increaing with maturation. CD5 is also expressed in a small subset of normal human B-cells (20% of B-cells in the peripheral blood, scattered cells in the lymph node mantle zone). The CD5+ cells are probably involved in B-T interaction and their ligand is CD72 which is expressed on all B cells. It appears that CD5+ B-cells on activation primarily produce IgM. They also produce more autoantibodies than normal CD5 negative B-cells. Thus, the CD5+ B-cell population is expanded in rheumatoid arthrititis and systemic lupus erythematosus. CD5 is detected in most T-cell lymphomas and leukaemias, including 75% of peripheral T-cell lymphomas and 85% of T-ALL cases. Lack of CD5 in the latter signifies a worse prognosis. Among B-cell lymphomas, more explicit CD20+ small-cell lymphomas, small lymphocytic lymphoma and mantle cell lymphoma are CD5+, whereas follicular lymphoma, marginal zone lymphoma and lymphoplasmacytoid lymphoma are CD5 negative. CD5 is detected in 5% of acute myeloid leukaemias. CD5 has been detected in some cases of thymic carcinoma and atypical thymoma. Other carcinomas are CD5 negative. Classification of small B-cell lymphomas, prognostication of T-ALL. Identification of large cell lymphoma (CD5 negative) supervening a CD5+ small lymphocytic lymphoma. Differentiation between reactive CD5+ T-cell infiltration and CD5 negative T-cell neoplasm. Identification of thymic carcinoma. Tonsil is recommendable as positive and negative tissue control, in which dispersed B-cells in the mantle zone of the secondary follicles must display a weak to moderate and distinct membranous staining reaction. T-cells will be strongly stained. No staining must be seen in the germinal center B-cells.
Background References
1. Durani U. et. al. CD5+ diffuse large B-cell lymphoma: a narrative review. Leuk Lymphoma. 2021 Dec
2. Xu Y. et. al. De Novo CD5(+) Diffuse Large B-Cell Lymphoma: Biology, Mechanism, and Treatment Advances. Clin Lymphoma Myeloma Leuk. 2020 Oct
Wash buffer: 1× TBST Endogenous peroxidase blocking: 3% H₂O₂, 10 minutes at room temperature. Blocking: 1% BSA + 10% normal goat serum, 10 minutes at room temperature. Primary antibody: HA721137, 1/2,000, 1 hour at room temperature. Secondary antibody: HA1119, 20 minutes at room temperature.
Application: IF-Tissue
Species: Human
Site: spleen
Sample: Paraffin-embedded section
Antibody concentration: 1/200
Western blot analysis of CD5 on Jurkat cell lysates with Rabbit anti-CD5 antibody (HA721137) at 1/5,000 dilution.
Lysates/proteins at 20 µg/Lane.
Predicted band size: 55 kDa Observed band size: 67 kDa
Exposure time: 1 minute; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (HA721137) at 1/5,000 dilution was used in primary antibody dilution (K1803) at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature.
Application: Immunohistochemistry (IHC-P)
Species: Human Tissue: Tonsil Sample: Paraffin-embedded section